Status:
RECRUITING
Longitudinal Study of CRS/HIPEC for Peritoneal Carcinomatoses
Lead Sponsor:
University of Regensburg
Collaborating Sponsors:
Krankenhaus Barmherzige Brüder, Regensburg
Conditions:
Peritoneal Carcinomatosis
Eligibility:
All Genders
18-80 years
Brief Summary
Longitudinal Study of the Effect of Cytoreductive Surgery and HIPEC in Patients With Peritoneal Carcinomatoses
Detailed Description
Cross-sectional and longitudinal analysis of cellular immune responses in the context of disease outcome. Cross-sectional and longitudinal analysis of the microbiome in the context of disease outcome...
Eligibility Criteria
Inclusion
- suspicious peritoneal carcinomatosis
Exclusion
- \<18 years
Key Trial Info
Start Date :
October 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2028
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT04108936
Start Date
October 1 2016
End Date
July 1 2028
Last Update
August 23 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Krankenhaus der Barmherzigen Brüder Regensburg
Regensburg, Bavaria, Germany, 93049
2
University Hospital Regensburg
Regensburg, Germany, 93053